Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1CNS 1

Conditions

Breast Neoplasms 20Leukemia 11Lymphoma 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Prostatic Neoplasms 6Lymphoma, Follicular 6Ovarian Neoplasms 5Neuroblastoma 5Kidney Neoplasms 5Carcinoma, Ovarian Epithelial 5Wilms Tumor 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Melanoma 4Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Acute 4Congenital Abnormalities 4Colorectal Neoplasms 4Colonic Neoplasms 4Central Nervous System Neoplasms 4Adenocarcinoma of Lung 4Testicular Neoplasms 3Myeloproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3

Interventions

avatrombopag 1Temozolomide 1Radiotherapy 1Platelet Transfusion 1Observation 1Comparative Genomic Hybridization 1Amplified Fragment Length Polymorphism Analysis 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Thrombocytopenia × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT00471653 2018-07-09

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Terminated
10 enrolled
CNSClassical hematologySarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Thrombocytopenia, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡